Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
US-9216970-B2 · Dec 22, 2015 · US
US9035044B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9035044-B2 |
| Application number | US-201213466249-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 8, 2012 |
| Priority date | May 9, 2011 |
| Publication date | May 19, 2015 |
| Grant date | May 19, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing said co-crystals and their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
Opening claim text (preview).
What is claimed: 1. An L-proline co-crystal of a compound of formula (I-X) 2. The L-proline co-crystal as in claim 1 , comprising the following pXRD peaks °2θ: 3.74, 9.50, 10.98, 17.78, 18.62, 21.94, 23.43 and 26.82; wherein the pXRD peaks are measured using Cu/K g λ1.54056Å radiation. 3. The L-proline co-crystal as in claim 1 , wherein the co-crystal exhibits a melting point of 188° C., as measured by DSC. 4. A citric acid co-crystal of a compound of formula (I-X) 5. The citric acid co-crystal as in claim 4 , comprising the following pXRD peaks °2θ: 4.2, 9.16, 12.39, 16.54, 17.69, 19.70, 23.63 and 25.66 wherein the pXRD peaks are measured using Cu/K α λ1.54056Å radiation. 6. The citric acid co-crystal as in claim 4 , wherein the co-crystal exhibits a melting point of about 156° C., as measured by DSC.
for hyperglycaemia, e.g. antidiabetics · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Tricarboxylic acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.